Regenxbio will receive $110m upfront from Nippon Shinyaku and is eligible to get up to $700m in development, regulatory, and sales milestones.
Is AI creating a new cognitive caste system—not between haves and have-nots, but between those who think with machines and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback